Rankings
▼
Calendar
NPCE FY 2023 Earnings — NeuroPace, Inc. Revenue & Financial Results | Market Cap Arena
NPCE
NeuroPace, Inc.
$482M
FY 2023 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$65M
+43.7% YoY
Gross Profit
$48M
73.6% margin
Operating Income
-$27M
-41.5% margin
Net Income
-$33M
-50.4% margin
EPS (Diluted)
$-1.27
Cash Flow
Operating Cash Flow
-$20M
Free Cash Flow
-$20M
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$108M
Total Liabilities
$87M
Stockholders' Equity
$21M
Cash & Equivalents
$18M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$65M
$46M
+43.7%
Gross Profit
$48M
$32M
+48.1%
Operating Income
-$27M
-$41M
+33.4%
Net Income
-$33M
-$47M
+30.0%
← Q4 2022
All Quarters
Q1 2023 →